These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9935199)

  • 1. Expression of facilitative glucose transport proteins during development of squamous cell carcinomas of the head and neck.
    Reisser C; Eichhorn K; Herold-Mende C; Born AI; Bannasch P
    Int J Cancer; 1999 Jan; 80(2):194-8. PubMed ID: 9935199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of GLUT-1 immunoreactivity to distinguish benign from malignant cystic squamous lesions of the head and neck in fine-needle aspiration biopsy material.
    Weiner MF; Miranda RN; Bardales RH; Mukunyadzi P; Baker SJ; Korourian S; De Las Casas LE
    Diagn Cytopathol; 2004 Nov; 31(5):294-9. PubMed ID: 15468132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glucose uptake in malignant tumors of the head and neck].
    Reisser C; Eichhorn K; Herold-Mende C
    HNO; 1999 Aug; 47(8):712-7. PubMed ID: 10506498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of SGLT-1 in preneoplastic and neoplastic lesions of the head and neck.
    Helmke BM; Reisser C; Idzko M; Dyckhoff G; Herold-Mende C
    Oral Oncol; 2004 Jan; 40(1):28-35. PubMed ID: 14662412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON.
    Jonathan RA; Wijffels KI; Peeters W; de Wilde PC; Marres HA; Merkx MA; Oosterwijk E; van der Kogel AJ; Kaanders JH
    Radiother Oncol; 2006 Jun; 79(3):288-97. PubMed ID: 16730088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Glut-1 in primary and recurrent head and neck squamous cell carcinomas, and compared with 2-[18F]fluoro-2-deoxy-D-glucose accumulation in positron emission tomography.
    Li SJ; Guo W; Ren GX; Huang G; Chen T; Song SL
    Br J Oral Maxillofac Surg; 2008 Apr; 46(3):180-186. PubMed ID: 18093707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.
    Kato H; Takita J; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
    Anticancer Res; 2003; 23(4):3263-72. PubMed ID: 12926062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of FDG single-photon emission computed tomography: Computed tomography in the diagnosis of head and neck cancers and study of its mechanism.
    Li LF; Zhou SH; Zhao K; Wang SQ; Wu QL; Fan J; Cheng KJ; Ling L
    Cancer Biother Radiopharm; 2008 Dec; 23(6):701-14. PubMed ID: 19317609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness.
    Kato H; Takita J; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(5):2635-9. PubMed ID: 12529975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy.
    De Schutter H; Landuyt W; Verbeken E; Goethals L; Hermans R; Nuyts S
    BMC Cancer; 2005 Apr; 5():42. PubMed ID: 15847702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of GLUT-1 immunolocalization in cell blocks: An adjunct to the fine needle aspiration diagnosis of cystic squamous lesions of the head and neck.
    Chandan VS; Faquin WC; Wilbur DC; Khurana KK
    Cancer; 2006 Apr; 108(2):124-8. PubMed ID: 16435376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of Glut-1 glucose transporter expression with.
    Higashi K; Ueda Y; Sakurai A; Wang XM; Xu L; Murakami M; Seki H; Oguchi M; Taki S; Nambu Y; Tonami H; Katsuda S; Yamamoto I
    Eur J Nucl Med; 2000 Dec; 27(12):1778-85. PubMed ID: 11189940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in the expression of glucose transporter protein GLUT 2 in preneoplastic and neoplastic hepatic lesions and reexpression of GLUT 1 in late stages of hepatocarcinogenesis.
    Grobholz R; Hacker HJ; Thorens B; Bannasch P
    Cancer Res; 1993 Sep; 53(18):4204-11. PubMed ID: 8364915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GLUT-1 Expression in Cutaneous Basal and Squamous Cell Carcinomas.
    Abdou AG; Eldien MM; Elsakka D
    Int J Surg Pathol; 2015 Sep; 23(6):447-53. PubMed ID: 26092229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma.
    Kunkel M; Reichert TE; Benz P; Lehr HA; Jeong JH; Wieand S; Bartenstein P; Wagner W; Whiteside TL
    Cancer; 2003 Feb; 97(4):1015-24. PubMed ID: 12569601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage.
    Ito T; Noguchi Y; Satoh S; Hayashi H; Inayama Y; Kitamura H
    Mod Pathol; 1998 May; 11(5):437-43. PubMed ID: 9619596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
    Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
    J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
    Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A preliminary study on the relationship between GLUT-1，MCT-4 and CAⅨ in laryngeal squamous cell carcinoma].
    Wang YB; Xu O; Zhang RJ; Shan CG
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Apr; 31(7):510-514;519. PubMed ID: 29871299
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative metabolic analysis in head and neck cancer and the normal gingiva.
    Voelxen NF; Blatt S; Knopf P; Henkel M; Appelhans C; Righesso LAR; Pabst A; Goldschmitt J; Walenta S; Neff A; Mueller-Klieser W; Ziebart T
    Clin Oral Investig; 2018 Mar; 22(2):1033-1043. PubMed ID: 28735466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.